Literature DB >> 33971899

WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting.

Belinda De Simone1, Justin Davies2, Elie Chouillard3, Salomone Di Saverio4, Frank Hoentjen5, Antonio Tarasconi6, Massimo Sartelli7, Walter L Biffl8, Luca Ansaloni9, Federico Coccolini10, Massimo Chiarugi10, Nicola De'Angelis11, Ernest E Moore12, Yoram Kluger13, Fikri Abu-Zidan14, Boris Sakakushev15, Raul Coimbra16, Valerio Celentano17, Imtiaz Wani18, Tadeja Pintar19, Gabriele Sganga20, Isidoro Di Carlo21, Dario Tartaglia22, Manos Pikoulis23, Maurizio Cardi24, Marc A De Moya25, Ari Leppaniemi26, Andrew Kirkpatrick27, Vanni Agnoletti28, Gilberto Poggioli29, Paolo Carcoforo30, Gian Luca Baiocchi31, Fausto Catena6.   

Abstract

BACKGROUND: Despite the current therapeutic options for the treatment of inflammatory bowel disease, surgery is still frequently required in the emergency setting, although the number of cases performed seems to have decreased in recent years. The World Society of Emergency Surgery decided to debate in a consensus conference of experts, the main pertinent issues around the management of inflammatory bowel disease in the emergent situation, with the need to provide focused guidelines for acute care and emergency surgeons.
METHOD: A group of experienced surgeons and gastroenterologists were nominated to develop the topics assigned and answer the questions addressed by the Steering Committee of the project. Each expert followed a precise analysis and grading of the studies selected for review. Statements and recommendations were discussed and voted at the Consensus Conference of the 6th World Society of Emergency Surgery held in Nijmegen (The Netherlands) in June 2019.
CONCLUSIONS: Complicated inflammatory bowel disease requires a multidisciplinary approach because of the complexity of this patient group and disease spectrum in the emergency setting, with the aim of obtaining safe surgery with good functional outcomes and a decreasing stoma rate where appropriate.

Entities:  

Keywords:  Abscess; Crohn’s disease; Damage control surgery; Emergency surgery; Inflammatory bowel disease; Laparoscopy; Open abdomen; Percutaneous drainage; Perforation; Perianal sepsis; Peritonitis; SILS; Toxic megacolon; Ulcerative colitis

Year:  2021        PMID: 33971899     DOI: 10.1186/s13017-021-00362-3

Source DB:  PubMed          Journal:  World J Emerg Surg        ISSN: 1749-7922            Impact factor:   5.469


  98 in total

1.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

Review 2.  Imaging and laboratory testing in acute abdominal pain.

Authors:  Nova L Panebianco; Katherine Jahnes; Angela M Mills
Journal:  Emerg Med Clin North Am       Date:  2011-05       Impact factor: 2.264

3.  Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.

Authors:  Steven F G Jeuring; Tim R A van den Heuvel; Limmie Y L Liu; Maurice P Zeegers; Wim H Hameeteman; Mariëlle J L Romberg-Camps; Liekele E Oostenbrug; Ad A M Masclee; Daisy M A E Jonkers; Marieke J Pierik
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864

Review 4.  Acute severe ulcerative colitis: State of the art treatment.

Authors:  Javier P Gisbert; María Chaparro
Journal:  Best Pract Res Clin Gastroenterol       Date:  2018-05-12       Impact factor: 3.043

5.  Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.

Authors:  Geert D'Haens; Marc Ferrante; Severine Vermeire; Filip Baert; Maja Noman; Liesbeth Moortgat; Patricia Geens; Doreen Iwens; Isolde Aerden; Gert Van Assche; Gust Van Olmen; Paul Rutgeerts
Journal:  Inflamm Bowel Dis       Date:  2012-02-16       Impact factor: 5.325

Review 6.  C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.

Authors:  Mahmoud H Mosli; Guangyong Zou; Sushil K Garg; Sean G Feagan; John K MacDonald; Nilesh Chande; William J Sandborn; Brian G Feagan
Journal:  Am J Gastroenterol       Date:  2015-05-12       Impact factor: 10.864

Review 7.  The epidemiology of inflammatory bowel disease: East meets west.

Authors:  Wing Yan Mak; Mirabella Zhao; Siew Chien Ng; Johan Burisch
Journal:  J Gastroenterol Hepatol       Date:  2019-11-24       Impact factor: 4.029

Review 8.  Acute surgical emergencies in inflammatory bowel disease.

Authors:  Dale F Berg; Anil M Bahadursingh; Donald L Kaminski; Walter E Longo
Journal:  Am J Surg       Date:  2002-07       Impact factor: 2.565

9.  Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.

Authors:  Mirthe Emilie van der Valk; Marie-Josée J Mangen; Max Leenders; Gerard Dijkstra; Ad A van Bodegraven; Herma H Fidder; Dirk J de Jong; Marieke Pierik; C Janneke van der Woude; Mariëlle J L Romberg-Camps; Cees H M Clemens; Jeroen M Jansen; Nofel Mahmmod; Paul C van de Meeberg; Andrea E van der Meulen-de Jong; Cyriel Y Ponsioen; Clemens J M Bolwerk; J Reinoud Vermeijden; Peter D Siersema; Martijn G H van Oijen; Bas Oldenburg
Journal:  Gut       Date:  2012-11-07       Impact factor: 23.059

10.  Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study.

Authors:  Levente Parragi; N Fournier; Jonas Zeitz; Michael Scharl; Thomas Greuter; Philipp Schreiner; Benjamin Misselwitz; Ekaterina Safroneeva; A M Schoepfer; Stephan R Vavricka; Gerhard Rogler; Luc Biedermann
Journal:  J Crohns Colitis       Date:  2018-06-28       Impact factor: 9.071

View more
  8 in total

Review 1.  Surgical Planning in Penetrating Abdominal Crohn's Disease.

Authors:  Pär Myrelid; Mattias Soop; Bruce D George
Journal:  Front Surg       Date:  2022-05-03

Review 2.  Therapeutic strategies in Crohn's disease in an emergency surgical setting.

Authors:  Maria Michela Chiarello; Gilda Pepe; Valeria Fico; Valentina Bianchi; Giuseppe Tropeano; Gaia Altieri; Giuseppe Brisinda
Journal:  World J Gastroenterol       Date:  2022-05-14       Impact factor: 5.374

3.  Magnesium-A Potential Key Player in Inflammatory Bowel Diseases?

Authors:  Georgiana-Emmanuela Gilca-Blanariu; Anca Trifan; Manuela Ciocoiu; Iolanda Valentina Popa; Alexandru Burlacu; Gheorghe G Balan; Andrei Vasile Olteanu; Gabriela Stefanescu
Journal:  Nutrients       Date:  2022-05-03       Impact factor: 6.706

4.  Vagus Nerve Stimulation Reduces Indomethacin-Induced Small Bowel Inflammation.

Authors:  April S Caravaca; Yaakov A Levine; Anna Drake; Michael Eberhardson; Peder S Olofsson
Journal:  Front Neurosci       Date:  2022-01-12       Impact factor: 4.677

5.  Non-toxic Megacolon Secondary to High-Grade Large-Bowel Obstruction.

Authors:  Nathan D Mullen; Hunter Thurn; Eric Karr; Kathryn M Burtson
Journal:  Cureus       Date:  2022-01-25

6.  Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn's Disease.

Authors:  Simon Kusan; Güzin Surat; Matthias Kelm; Friedrich Anger; Mia Kim; Christoph-Thomas Germer; Nicolas Schlegel; Sven Flemming
Journal:  J Clin Med       Date:  2022-07-26       Impact factor: 4.964

7.  Associations between inflammatory bowel disease, social isolation, and mortality: evidence from a longitudinal cohort study.

Authors:  Jie Chen; Jiawei Geng; Jiayi Wang; Zhenhua Wu; Tian Fu; Yuhao Sun; Xuejie Chen; Xiaoyan Wang; Therese Hesketh
Journal:  Therap Adv Gastroenterol       Date:  2022-09-30       Impact factor: 4.802

8.  Assessment of influencing factors of hospitalization expenses for Crohn's disease patients: Based on LASSO and linear mixed model.

Authors:  Li Wu; Zhijie Lv; Linjing Lai; Penglei Zhou
Journal:  Front Public Health       Date:  2022-09-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.